Corpus Intelligence IC Memo — ACADIA-ST. LANDRY HOSPITAL 2026-04-26 12:48 UTC
IC Memo — ACADIA-ST. LANDRY HOSPITAL
Investment Committee Memorandum | LA | 15 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ACADIA-ST. LANDRY HOSPITAL

CCN 191319 | ACADIA PARISH, LA | 15 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ACADIA-ST. LANDRY HOSPITAL is a 15-bed rural/critical access in ACADIA PARISH, LA with $15.5M in net patient revenue and a -6.3% operating margin. The hospital serves a payer mix of 81.4% Medicare, 0.3% Medicaid, and 18.3% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.3% to 1.1% (+736bps).

Net Revenue HCRIS$15.5M
Current EBITDA COMPUTED$-979K
Operating Margin COMPUTED-6.3%
Occupancy HCRIS42.4%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS110.3%
Distress Probability ML58.9%

2. Market Context & Competitive Position

212
LA Hospitals
-3.5%
State Median Margin
88
Comparable Hospitals

LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -6.3% places it below the state median. Among 88 size-comparable peers (8-30 beds), the median margin is -1.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-30), prioritizing same-state peers. 88 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ACADIA-ST. LANDRY HOSPITAL (Target)LA15$15.5M-6.3%
SPECIALISTS HOSPITAL OF SHREVELA15$79.1M21.3%
OCHSNER BAYOU LLCLA25$76.5M-0.9%
CENTRAL LOUISIANA SURGICAL HOSLA24$69.1M7.7%
ST. CHARLES PARISH HOSPITALLA27$64.0M-5.1%
AVALALA21$64.0M7.4%
THE SPINE HOSPITAL OF LOUISIANLA23$57.4M35.4%
PARK PLACE SURGERY CENTERLA10$51.6M15.4%
SURGICAL SPECIALTY CENTER BATOLA16$49.8M16.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$326K+210bp18mo
Cost to Collect4.5%2.5%$311K+200bp12mo
Denial Rate Reduction12.0%6.5%$308K+198bp12mo
A/R Days Reduction5200.0%3800.0%$189K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$326K
Cost to Collect
$311K
Denial Rate Reduction
$308K
A/R Days Reduction
$189K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-979K
+ RCM Uplift+$1.1M
Pro Forma EBITDA$166K
Current Margin-6.3%
Pro Forma Margin1.1%
WC Released (1x)$596K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.5M$5.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.5M$5.0M0.00x-100.0%
Bull Case9.0x11.0x$-1.4M$8.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.4M$8.6M0.00x-100.0%
Bear Case11.0x10.0x$-1.7M$-246K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.7M$-808K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 81.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 58.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 88 hospitals with 8-30 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-14.3% / P50=-1.5% / P75=8.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.